Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards recall
Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards, packaged in boxes containing Levels 1-6, 1 x 4 mL each, REF 2450-604, Medline catalog number S-O2450604, IVD.
Why was Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards recalled?
The product was stored incorrectly due to improper storage controls which may lead to delayed results.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot numbers 172093, exp. 06/30/2023; 174703, exp. 08/31/2023; and 169141, exp. 04/30/2023.
- Product
- Stanbio TDM/Beta-Hydroxybutyrate Linearity Standards, packaged in boxes containing Levels 1-6, 1 x 4 mL each, REF 2450-604, Medline catalog number S-O2450604, IVD.
- Recalling firm
- MEDLINE INDUSTRIES, LP - Northfield
- Quantity
- 10 boxes
- Distribution
- Distribution was made to AL, FL, NE OH, TX, WA, and WI. There was no foreign/military/government distribution.
- Recall date
- April 20, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (device)